Organizers



List of participants

back to list
Company

BIOGLANE, S.L.N.E.

Street
JORDI GIRONA
ZIP Code
08034
City
BARCELONA
Country
Spain


Company Profile:
Bioglane is a science driven company that manufactures innovative active ingredients based on competitive and exclusive advanced technologies. This spin-off from the Spanish Research Council (CSIC) has developed enzymatic processes for the competitive production at large scale of natural iminosugars and other rare sugars, most of which are not available today in industrial quantities.
Bioglane has focused on D-fagomine, a little known natural iminosugar present in the human diet for centuries. The company has scaled up its industrial production of this active under FDA-GMP and is now expanding its contacts with food manufacturers for the joint development of new, exclusive food products using D-fagomine in a range of applications.
Bioglane is well positioned to secure exclusive agreements with partners in functional food and animal nutrition, in addition to human and animal health for OTC applications based on exclusive competitive manufacture, supply and patented use of D-fagomine.
Profiltitel

D-fagomine: Healthy nutritional ingredient to balance refined carbohydrates in the diet (for healthy people).

What we offer:
D-fagomine is one of the more simple glucose analogs present in nature and represents the unique mass-marketing of a healthy nutritional ingredient to balance refined carbohydrates in the diet (for healthy people) what is recognized as a global health challenge, and also the company has exclusive relevant uses based on natural selective improvement of D-fagomine’s microbiota properties, discovered and patented by Bioglane that broadens D-fagomine’s potential market to include not only human diet and nutrition but also animal nutrition and novel OTC developments (oral, gut and urinary health).

What are we looking for:
Bioglane is well positioned to secure exclusive agreements with partners in functional food and animal nutrition, in addition to human and animal health for OTC applications based on exclusive competitive manufacture, supply and patented use of D-fagomine.

The company takes part in several transnational European R&D projects (2010-2013) related to innovative industrial bioprocesses using biocatalysts, and is willing to be involved in FP7 projects (food & NP developement).

Also is seeking additional capital up to Eur 2 million to complete the international launch of D-fagomine in the nutritional market, starting in the United States at the end of 2012.

Keywords:
  • ] Pharmaceutics
  • ] Food additives / Ingredients / Fuctional Food


Collaboration sought:
  • FP7 Project
  • Research and development


Responsible

Mr Sergio Pumarola


back to list

Participants

© 2011 ConVerve GmbH | all rights reserved